Life Sciences Tools and Services
Company Overview of Patheon Holdings Coöperatief U.A.
Patheon Holdings Coöperatief U.A. provides outsourced pharmaceutical development and manufacturing services. The company offers a range of active pharmaceutical ingredient and finished drug product services, including formulation development, as well as clinical and commercial-scale manufacturing, packaging, and lifecycle management. It caters to small molecule and large molecule biological drugs sectors. Patheon Holdings Coöperatief U.A. was incorporated in 2013 and is based in Amsterdam, the Netherlands.
Founded in 2013
Key Executives for Patheon Holdings Coöperatief U.A.
Chief Financial Officer and Executive Vice President of Finance and Information Technology and Director
Executive Vice President of Corporate Development & Strategy and President of Banner Life Sciences
President of Drug Substance
President of Global Pharmaceutical Development Services and Executive Vice President of Global Sales & Marketing
Compensation as of Fiscal Year 2015.
Patheon Holdings Coöperatief U.A. Key Developments
Jaguar Animal Health Signs Crofelemer Formulation Development and Manufacturing Contract with Patheon
Oct 15 15
Jaguar Animal Health Inc. announced that it has signed a crofelemer formulation development and manufacturing contract with Patheon. Crofelemer is an active pharmaceutical ingredient (API) in Canalevia™, Jaguar’s prescription drug product candidate for the treatment of various forms of acute diarrhea in dogs. Under the terms of the contract, Patheon will provide enteric-coated crofelemer tablets for Jaguar for use in animals. The tablets will be used in Jaguar’s pivotal efficacy trial for Canalevia™, scheduled to begin in the fourth quarter of this year. Jaguar expects to use safety and effectiveness data from this trial in support of the initiation of the filing of a new animal drug application (NADA) with the FDA for Canalevia™ in 2016 for the indication of acute diarrhea in dogs.
Patheon Holdings Coöperatief U.A. Presents at BIO-Europe 2015, Nov-02-2015
Oct 1 15
Patheon Holdings Coöperatief U.A. Presents at BIO-Europe 2015, Nov-02-2015 . Venue: Munich, Germany.
Patheon Inc. Invests More Than $3 Million to Expand Testing Capabilities at its Stability Lab in Greenville, North Carolina
May 27 15
Patheon Inc. invested more than $3 million to expand testing capabilities at its stability lab in Greenville, North Carolina. The expansion includes the addition of the most advanced automated systems and the assembly of a highly experienced scientific team to enhance its centralized stability lab offerings. With this expansion, the facility now offers more than 30,000 cubic feet of stability storage, and the capabilities to support the largest, most complex projects on small molecule APIs, large molecule biologics and drug substances, solid oral dose drugs, sterile liquid or lyophilized drugs, controlled substances and highly potent compounds.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries